证券日报网讯 2月27日，帝奥微发布公告称，公司2025年实现营业收入56，204.64万元，同比增长 6.80%；归属于母公司所有者的净利润为-7，003.99万元，较上年同期增加亏损2，297.17万元。 （文章来源：证券日报） ...

报告期内，公司不断加大研发投入，丰富产品矩阵，对产品进行性能和质量提升，因此在不断加剧的市 场竞争环境下，公司产品毛利率仍达到了42.89%。同时公司加大新产品推广力度，拓宽下游销售渠 道，提升大客户份额。因此公司的研发费用和销售费用均有所增长，较上年合计增加3,641.57万元，增 长14.22%，从而导致公司本期利润下降。 格隆汇2月27日丨帝奥微(688381.SH)公布2025年度业绩快报，报告期内，公司实现营业收入56,204.64万 元，较上年同期（法定披露数据）增长6.80%；实现归属于母公司所有者的净利润-7,003.99万元，较上 年同期（法定披露数据）增加亏损2,297.17万元；实现归属于母公司所有者的扣除非经常性损益的净利 润-12,923.70万元，较上年同期（法定披露数据）增加亏损3,555.73万元。 ...

江苏帝奥微电子股份有限公司 2025 年年度业绩快报公告 证券代码：688381 证券简称：帝奥微 公告编号：2026-003 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 重要内容提示： 本公告所载 2025 年度主要财务数据为初步核算数据，未经会计师事务所审 计，具体数据以公司 2025 年年度的定期报告为准，提请投资者注意投资风险。 一、2025 年度主要财务数据和指标 单位：人民币万元 | 项目 | 本报告期 | 上年同期 | 增减变动幅度 | | --- | --- | --- | --- | | | | | （％） | | 营业总收入 | 56,204.64 | 52,624.54 | 6.80 | | 营业利润 | -7,539.34 | -4,863.02 | 不适用 | | 利润总额 | -7,559.58 | -4,904.96 | 不适用 | | 归属于母公司所有 者的净利润 | -7,003.99 | -4,706.82 | 不适用 | | 归属于母公司所有 者的扣除非经常性 损益的净利润 | - ...

格隆汇2月27日｜帝奥微公告，公司2025年实现营业收入56,204.64万元，较上年同期增长6.80%；实现 归属于母公司所有者的净利润-7,003.99万元，较上年同期增加亏损2,297.17万元；实现归属于母公司所 有者的扣除非经常性损益的净利润-12,923.70万元，较上年同期增加亏损3,555.73万元。报告期内，公司 不断加大研发投入，丰富产品矩阵，对产品进行性能和质量提升，因此在不断加剧的市场竞争环境下， 公司产品毛利率仍达到了42.89%。 ...

Core Viewpoint - On February 23, a total of 34 listed companies had their restricted shares unlocked, with a total market value of approximately 19.007 billion yuan [1] Group 1: Restricted Share Unlocking Details - Luzhou Laojiao (000568) had 2.0425 million shares unlocked under equity incentive restrictions - AVIC Xi'an Aircraft Industry (000768) had 4.3606 million shares unlocked under equity incentive restrictions - Hubei Energy (000883) had 19.2779 million shares unlocked under equity incentive restrictions - Jining Pharmaceutical (000919) had 1.92 million shares unlocked under equity incentive restrictions - Guangji Pharmaceutical (000952) had 2.5209 million shares unlocked under equity incentive restrictions - China Software (600536) had 57,200 shares unlocked under equity incentive restrictions - Xinhua Medical (600587) had 1.7845 million shares unlocked under equity incentive restrictions - Baoxin Software (600845) had 10.2578 million shares unlocked under equity incentive restrictions - China Railway (601390) had 55.9338 million shares unlocked under equity incentive restrictions - China Communications Construction (601800) had 5.593 million shares unlocked under equity incentive restrictions - StarNet Ruijie (002396) had 2.8342 million shares unlocked under equity incentive restrictions - Lopuskin (002333) had 22.3212 million shares unlocked under A-share issuance to legal persons - Wanbangda (300055) had 33.6538 million shares unlocked under A-share issuance to legal persons - Hangyang Co., Ltd. (002430) had 5.2049 million shares unlocked under equity incentive restrictions - Taijia Co., Ltd. (002843) had 949,600 shares unlocked under equity incentive restrictions - Nanda Optoelectronics (300346) had 130,000 shares unlocked under equity incentive restrictions - Anhui Natural Gas (603689) had 2.5064 million shares unlocked under equity incentive restrictions - Zhongyan Dadi (003001) had 97,200 shares unlocked under equity incentive restrictions - Yuanxiang New Materials (301300) had 30.2983 million shares unlocked with extended lock-up period - Yidao Information (001314) had 88.6187 million shares unlocked under pre-issuance restrictions - Tongda Electric (603390) had 579,500 shares unlocked under equity incentive restrictions - Yangzhou Jinqiao (603307) had 50 million shares unlocked under pre-issuance restrictions - Aili Home (603221) had 2.29 million shares unlocked under equity incentive restrictions - Zhili Fang (301312) had 333,900 shares unlocked under equity incentive restrictions - Kuntai Co., Ltd. (001260) had 83.25 million shares unlocked under pre-issuance restrictions - Entropy Technology (301330) had 92.5223 million shares unlocked with extended lock-up period - Yatong Precision (603190) had 596,100 shares unlocked under pre-issuance restrictions - Sanwang Communication (688618) had 87,400 shares unlocked - Longxun Co., Ltd. (688486) had 30.6312 million shares unlocked - Dize Pharmaceutical (688192) had 991,100 shares unlocked - Haohan Depth (688292) had 57.5177 million shares unlocked - Haizheng Biomaterials (688203) had 78.5601 million shares unlocked - Diaomicro (688381) had 55.9536 million shares unlocked - Zhongrun Optics (688307) had 29.8507 million shares unlocked [1]

Group 1 - The company, DiAo Microelectronics, expects to achieve an operating revenue of approximately 562 million yuan in 2025, representing an increase of 35.75 million yuan or 6.79% year-on-year [1] - The company anticipates a net loss attributable to shareholders of the parent company ranging from 55 million to 82 million yuan for 2025, a decrease of 7.93 million to 34.93 million yuan compared to the previous year, reflecting a year-on-year decline of 16.85% to 74.22% [1] - The expected net loss excluding non-recurring gains and losses for 2025 is projected to be between 112 million and 139 million yuan, which is a deterioration of 18.32 million to 45.32 million yuan compared to the previous year, indicating an increase in loss of 19.56% to 48.38% [1] Group 2 - DiAo Microelectronics was listed on the Shanghai Stock Exchange's Sci-Tech Innovation Board on August 23, 2022, with a public offering of 63.05 million shares at a price of 41.68 yuan per share [2] - The stock reached a peak price of 55.50 yuan on its first trading day, which remains the highest price since its listing, but is currently in a state of decline [2] - The total amount raised from the initial public offering was approximately 2.63 billion yuan, with a net amount of 2.42 billion yuan after deducting issuance costs, exceeding the original plan by 915.60 million yuan [2]

证券代码：688381 证券简称：帝奥微 公告编号：2026-002 江苏帝奥微电子股份有限公司 首次公开发行部分限售股上市流通公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 重要内容提示： 本次股票上市类型为首发限售股份；股票认购方式为网下，上市股数为 55,953,600股。 本次股票上市流通总数为55,953,600股。 本次股票上市流通日期为2026 年 2 月 24 日。（因 2 月 23 日为非交易日， 故顺延至下一个交易日） 根据《江苏帝奥微电子股份有限公司首次公开发行股票并在科创板上市招 股说明书》及《江苏帝奥微电子股份有限公司首次公开发行股票科创板上市公告 书》，公司控股股东、实际控制人、董事长、总经理及核心技术人员鞠建宏；公司 实际控制人、董事周健华；公司实际控制人之原一致行动人郑慧；公司股东安泰 房地产均承诺：自锁定期届满之日起 24 个月内，若本人通过任何途径或手段减持 发行人首次公开发行股票前本人直接或间接持有的发行人股票，则本人的减持价 格应不低于发行人首次公开发行股票的发行价格。若发行人 ...

Group 1 - The company Diao Micro announced that 55.9536 million restricted shares will be unlocked and listed for circulation on February 24, 2026, accounting for 22.61% of the company's total share capital [1] Group 2 - The central bank, which has been the largest buyer of gold for two consecutive years, announced plans to purchase an additional 150 tons of gold, aiming to accumulate a total of 700 tons [1]

中信建投证券股份有限公司 关于江苏帝奥微电子股份有限公司 首次公开发行部分限售股上市流通的核查意见 中信建投证券股份有限公司（以下简称"中信建投证券"、"本保荐机构"） 作为江苏帝奥微电子股份有限公司（以下简称"帝奥微"、"公司"）首次公开 发行股票并在科创板上市的保荐机构，根据《证券发行上市保荐业务管理办法》 《上海证券交易所科创板股票上市规则》《上海证券交易所上市公司自律监管指 引第 11 号——持续督导》等有关规定，对帝奥微首次公开发行部分限售股上市 流通事项进行了审慎核查，具体情况如下： 一、本次上市流通的限售股类型 根据中国证券监督管理委员会（以下简称"中国证监会"）于 2022 年 6 月 15 日出具的《关于同意江苏帝奥微电子股份有限公司首次公开发行股票注册的 批复》（证监许可〔2022〕1249 号），同意公司首次公开发行股票的注册申请。 公司首次公开发行人民币普通股 6,305 万股，并于 2022 年 8 月 23 日在上海证券 交易所科创板挂牌上市。公司首次公开发行 A 股前总股本为 189,150,000 股，首 次公开发行 A 股后总股本为 252,200,000 股，其中有限售条件 ...

Group 1 - The company is currently developing a high-value analog-to-digital conversion product for OCS switches, indicating a forward-looking strategy in this field [1] - The company has received inquiries from investors regarding its involvement in the chip market for OCS switches, highlighting investor interest [1]